Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131
ECOG-ACRIN Cancer Research Group
Ingrid A Mayer; Fengmin Zhao; Carlos L Arteaga; William F Symmans; Ben H Park; Brian L Burnette; Amye J Tevaarwerk; Sofia F Garcia; Karen L Smith; Della F Makower; Margaret Block; Kimberly A Morley; Chirag R Jani; Craig Mescher; Shabana J Dewani; Bernard Tawfik; Lisa E Flaum; Erica L Mayer; William M Sikov; Eve T Rodler; Lynne I Wagner; Angela M DeMichele; Joseph A Sparano; Antonio C Wolff; Kathy D Miller
Dana-Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, MA.